Literature DB >> 9383699

Hypophosphatemia and the development of rickets in osteopetrotic (op/op) mice.

L C McCary1, C M Smith, H F DeLuca.   

Abstract

Our previous work has shown that op/op mice hyperabsorb dietary calcium in the vitamin D-deficient state and shunt that calcium into bone. Under these conditions, the op/op mice are hypocalcemic. The purpose of this study was to examine calcium metabolism and bone mineralization in vitamin D-deficient op/op mice. First, the op/op mice and their normal littermates were placed on a vitamin D-deficient, low phosphorus diet to limit bone mineralization. Under these circumstances, op/op mice survived, even when calcium was also removed from the diet. If the diet contained phosphate, op/op mice died from hypocalcemic tetany when calcium was also removed from the diet. Furthermore, serum calcium levels became similar to wild type in the op/op mice administered the vitamin D-deficient, low phosphorus diet, and op/op mice were able to increase serum calcium in response to 1,25-dihydroxyvitamin D3. The op/op mice developed rickets when their serum phosphorus level was too low to support bone mineralization. The op/op mice became hypophosphatemic on regimens in which normal mice were able to maintain normal serum phosphorus levels. It appears that the op/op mouse simply requires a higher dietary calcium and phosphorus level to prevent rickets and hypocalcemic tetany since the bone is not available as a source of these minerals. However, the ability of the op/op mouse to mineralize bone at low serum calcium and phosphorus levels remains unexplained.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383699     DOI: 10.1359/jbmr.1997.12.11.1944

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

1.  CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1alpha-hydroxylase promoter activity in the skin.

Authors:  Janeen L Vanhooke; Jean M Prahl; Christine Kimmel-Jehan; Monica Mendelsohn; Eric W Danielson; Kevin D Healy; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

2.  Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter.

Authors:  H L Brenza; C Kimmel-Jehan; F Jehan; T Shinki; S Wakino; H Anazawa; T Suda; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Increased connective tissue extracellular matrix in the op/op model of osteopetrosis.

Authors:  Zaher A Radi; Roberto E Guzman; Rosonald R Bell
Journal:  Pathobiology       Date:  2009-06-29       Impact factor: 4.342

4.  Restriction of Dietary Phosphate Ameliorates Skeletal Abnormalities in a Mouse Model for Craniometaphyseal Dysplasia.

Authors:  Yasuyuki Fujii; Eszter Kozak; Eliane Dutra; Andras Varadi; Ernst J Reichenberger; I-Ping Chen
Journal:  J Bone Miner Res       Date:  2020-07-12       Impact factor: 6.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.